Guardant Health (GH) CFO nets shares from RSU vesting and tax withholding
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Guardant Health, Inc.’s Chief Financial Officer Michael Brian Bell reported routine equity compensation activity involving restricted stock units that vested into common stock. On July 1, 2026, RSU conversions delivered 7,278 shares of common stock, while 3,914 shares were withheld at $170.77 per share to cover tax obligations, rather than sold in the open market.
Positive
- None.
Negative
- None.
Insider Trade Summary
7,278 shares exercised/converted
Mixed
7 txns
Insider
Bell Michael Brian
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 2,084 | $0.00 | -- |
| Exercise | Restricted Stock Units | 3,324 | $0.00 | -- |
| Exercise | Restricted Stock Units | 1,870 | $0.00 | -- |
| Exercise | Common Stock | 2,084 | $0.00 | -- |
| Exercise | Common Stock | 3,324 | $0.00 | -- |
| Exercise | Common Stock | 1,870 | $0.00 | -- |
| Tax Withholding | Common Stock | 3,914 | $170.77 | $668K |
Holdings After Transaction:
Restricted Stock Units — 2,085 shares (Direct, null);
Common Stock — 50,536 shares (Direct, null)
Footnotes (1)
- These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. Not applicable for Restricted Stock Units. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
Key Figures
Shares acquired via RSU exercise: 7,278 shares
Shares withheld for taxes: 3,914 shares
Tax withholding reference price: $170.77 per share
+3 more
6 metrics
Shares acquired via RSU exercise
7,278 shares
Total exercise or conversion shares on July 1, 2026
Shares withheld for taxes
3,914 shares
Retained by company to meet tax withholding obligations
Tax withholding reference price
$170.77 per share
Price for common stock in tax-withholding disposition
Single RSU exercise block
3,324 RSUs
One derivative transaction converting RSUs into common stock
Second RSU exercise block
2,084 RSUs
Another derivative transaction converting RSUs into common stock
Third RSU exercise block
1,870 RSUs
Additional derivative transaction converting RSUs into common stock
Key Terms
Restricted Stock Units, tax withholding obligations, derivative security, restricted stock unit award
4 terms
Restricted Stock Units financial
"This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting."
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
restricted stock unit award financial
"This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period."
A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.
FAQ
What did Guardant Health (GH) CFO Michael Brian Bell report in this Form 4?
He reported routine equity compensation activity. Restricted stock units vested into Guardant Health common stock, and a portion of the resulting shares was withheld by the company to satisfy tax withholding obligations related to the vesting event.
Were any of the Guardant Health CFO’s transactions open-market buys or sells?
No open-market purchases or sales were reported. The filing shows derivative exercises (code M) converting restricted stock units into common shares and a tax-withholding disposition (code F), where shares were retained by the company to satisfy tax obligations.
What are the vesting terms of the December 13, 2023 RSU grant at Guardant Health?
The December 13, 2023 restricted stock unit award vests over three years. Thirty-three percent vested on October 1, 2024, and the remaining 67% vests in equal quarterly installments over the following two-year period, as described in the footnotes.
What vesting schedule applies to the November 8, 2024 RSU award at Guardant Health?
The November 8, 2024 restricted stock unit grant also vests over three years. Thirty-three percent vested on October 1, 2025, with the remaining 67% vesting in equal quarterly installments during the subsequent two years, according to the disclosed footnote.
How does the March 12, 2025 Guardant Health RSU grant vest?
The March 12, 2025 restricted stock unit award vests over three years. Thirty-three percent vested on April 1, 2026, and the remaining 67% is scheduled to vest in equal quarterly installments over the next two years, consistent with the award’s stated vesting schedule.